Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$151.44 - $200.09 $38,465 - $50,822
254 New
254 $50,000
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $40,878 - $47,302
254 New
254 $43,000
Q3 2022

Nov 08, 2022

SELL
$148.29 - $182.55 $7,859 - $9,675
-53 Reduced 17.26%
254 $38,000
Q2 2022

Aug 11, 2022

SELL
$155.97 - $200.09 $12,945 - $16,607
-83 Reduced 21.28%
307 $53,000
Q1 2022

May 05, 2022

BUY
$181.39 - $234.03 $70,742 - $91,271
390 New
390 $74,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track O'Dell Group, LLC Portfolio

Follow O'Dell Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Dell Group, LLC with notifications on news.